30 DAY MORTALITY AFTER VALVE-REPLACEMENT FOR AORTIC-STENOSIS OVER THE LAST 22 YEARS - A MULTIVARIATE RISK STRATIFICATION

被引:28
作者
LUND, O [1 ]
PILEGAARD, H [1 ]
NIELSEN, TT [1 ]
KNUDSEN, MA [1 ]
MAGNUSSEN, K [1 ]
机构
[1] AARHUS UNIV HOSP,DEPT CARDIOL,DK-8200 AARHUS N,DENMARK
关键词
AORTIC VALVE STENOSIS; HEART VALVE REPLACEMENT; 30-DAY MORTALITY; OPERATIVE MORTALITY; RISK STRATIFICATION;
D O I
10.1093/oxfordjournals.eurheartj.a059897
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Over the last 22 years (1965-86), the 30-day mortality rate (30-DMR) after valve replacement for primary or predominant aortic stenosis (AS, N = 690) fell from 20.0% for the first 100 consecutive patients, via 7.8% for the next 490, to 2.0% for the final 100 (P < 00001). There was, however, a wide scatter in 30-DMR in the 11 consecutive 2-year periods, as well as during later years. The variation in 30-DMR was paralleled by changes in a high risk prognostic index (derived from a logistic regression model) and in a high coronary artery disease (CAD) score. In patients with a high CAD score who died within 30 days, 93% (N = 25) had CAD at autopsy compared with 37% (N = 11) of those with a low CAD score (P<0.0001). In 205 patients evaluated by coronary arteriography, the 30-DMR was 41% in 122 without CAD, 3.6% (3.8% for triple vessel/left main stem) for 55 with CAD who underwent bypass grafting, and 17.9% for 28 with CAD who did not have bypass grafting (P<0.0001). Left ventricular failure (LVF; episodes of pulmonary oedema and/or stasis), age, pronounced hypertrophy/strain in the ECG, and a high CAD score were independent incremental risk factors for 30-DMR. Quantitatively, LVF increased the risk 10 times more than pronounced hypertrophy /strain and a high CAD score. LVF also neutralized the influence of age. Modifying (symptom-masking) digitalis and/or diuretic treatment in functional class II patients (N = 189) increased the 30-DMR from 0.9% to 9.1% (P<0.01).The scatter of operative year-specific 30-DMR was related to changes in preoperative prognostic patient profiles and to unrevascularized CAD. Operative intervention in AS patients, even with discrete symptoms, and consistent revascularization of significant CAD, should be strongly advocated. © 1991 The European Society of Cardiology.
引用
收藏
页码:322 / 331
页数:10
相关论文
共 30 条
[1]  
ABDELNOOR M, 1988, REV EPIDEMIOL SANTE, V36, P89
[2]  
ACAR J, 1981, J THORAC CARDIOV SUR, V82, P114
[3]   THE DECOMPOSITION OF TIME-VARYING HAZARD INTO PHASES, EACH INCORPORATING A SEPARATE STREAM OF CONCOMITANT INFORMATION [J].
BLACKSTONE, EH ;
NAFTEL, DC ;
TURNER, ME .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1986, 81 (395) :615-624
[4]  
BRETSCHNEIDER HJ, 1975, J CARDIOVASC SURG, V16, P241
[5]  
CHRISTAKIS GT, 1988, CIRCULATION, V78, P25
[6]  
CRAVER JM, 1988, CIRCULATION, V78, P85
[7]  
CZER LSC, 1988, J THORAC CARDIOV SUR, V95, P390
[8]  
DELANY DJ, 1980, CARDIAC CATHETERIZAT, P197
[9]   IMPROVED EARLY RESULTS AFTER AORTIC-VALVE REPLACEMENT - ANALYSIS BY SURGICAL TIME FRAME [J].
DILELLO, F ;
FLEMMA, RJ ;
ANDERSON, AJ ;
MULLEN, DC ;
KLEINMAN, LH ;
WERNER, PH .
ANNALS OF THORACIC SURGERY, 1989, 47 (01) :51-56
[10]  
Dixon W.J, 1983, BMDP STATISTICAL SOF, P734